198 results on '"Bangert, Mathieu"'
Search Results
2. Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study
3. Respiratory Syncytial Virus in Outpatient Children with Bronchiolitis: Continuous Virus Circulation During the Nonepidemic Period
4. Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review.
5. Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study.
6. Determining the timing of respiratory syncytial virus (RSV) epidemics: a systematic review, 2016 to 2021; method categorisation and identification of influencing factors
7. The simplified trachoma grading system, amended/Modification du systeme de codage simplifie du trachome/Modificacion del sistema de clasificacion simplificada del tracoma
8. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
9. 1743. Health Care Resource Utilisation (HCRU) Due to Respiratory Syncytial Virus (RSV) Before the Age of Two in England
10. 889. The age of RSV cases changes consistently over the course of annual epidemics: potential insights into RSV transmission dynamics based on surveillance data from seven countries.
11. 89. The Impact of Nirsevimab on an RSV Season in All Infants: Data From The HARMONIE Study
12. Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022
13. Delayed Bronchiolitis Epidemic in French Primary Care Setting Driven by Respiratory Syncytial Virus: Preliminary Data from the Oursyn Study, March 2021
14. Monitoring equity in universal health coverage with essential services for neglected tropical diseases: an analysis of data reported for five diseases in 123 countries over 9 years
15. An augmented passive immunotherapy to treat pneumococcal diseases
16. Time-varying association between severe respiratory syncytial virus infections and subsequent severe asthma and wheeze and influences of age at the infection
17. Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshire and Bristol, UK
18. Assessing the burden of bronchiolitis and lower respiratory tract infections in children ≤24 months of age in Italy, 2012–2019
19. Respiratory Syncytial Virus (RSV) Hospital Admission Rates and Patients’ Characteristics Before the Age of Two in England, 2015-2019
20. Estimated need for anthelminthic medicines to control soil-transmitted helminthiases in school-aged children, 2020–2030
21. Sustained preventive chemotherapy for soil-transmitted helminthiases leads to reduction in prevalence and anthelminthic tablets required
22. Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years.
23. Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union.
24. Defining the Burden of Disease of RSV in the European Union: estimates of RSV-associated hospitalisations in children under 5 years of age. A systematic review and modelling study
25. Burden of Respiratory Syncytial Virus in the European Union:estimation of RSV-associated hospitalizations in children under 5 years
26. Estimation of the number of RSV-associated hospitalisations in adults in the European Union
27. Global prevalence of 4 neglected foodborne trematodes targeted for control by WHO: A scoping review to highlight the gaps
28. Defining the Burden of Disease of RSV in Europe: estimates of RSV-associated hospitalisations in children under 5 years of age. A systematic review and modelling study
29. Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018
30. Laboratory testing for Zika virus and dengue virus infections: interim guidance
31. Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis
32. Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries
33. Preventive chemotherapy in one year reduces by over 80% the number of individuals with soil-transmitted helminthiases causing morbidity: results from meta-analysis
34. Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018.
35. P4-Mediated Antibody Therapy in an Acute Model of Invasive Pneumococcal Disease
36. Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets
37. Airborne dust and high temperatures are risk factors for invasive bacterial disease
38. Non-Appearance of the RSV Season 2020/21 During the COVID-19 Pandemic
39. Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries
40. The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries
41. Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination
42. Hospital Admission Trends for Bronchiolitis in Scotland, 2001–2016: A National Retrospective Observational Study
43. The Importance of Failure: How Doing Impact Surveys That Fail Saves Trachoma Programs Money
44. Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults
45. The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries
46. Additional file 2: of Sustained preventive chemotherapy for soil-transmitted helminthiases leads to reduction in prevalence and anthelminthic tablets required
47. Additional file 3: of Sustained preventive chemotherapy for soil-transmitted helminthiases leads to reduction in prevalence and anthelminthic tablets required
48. Additional file 1: of Sustained preventive chemotherapy for soil-transmitted helminthiases leads to reduction in prevalence and anthelminthic tablets required
49. Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B
50. Economic analysis of dengue prevention and case management in the Maldives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.